FDA Inspection 1035304 — BASF Corporation
The FDA completed an inspection of BASF Corporation on Dec 12, 2017 in Washington, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Veterinary.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Dec 12, 2017
- Fiscal Year
- 2018
- Product Type
- Veterinary
- Project Area
- Monitoring of Marketed Animal Drugs, Feed, and Devices
- Location
- Washington, NJ (United States)